// App-Quantinova.ai

OC 12.2 : Safety and Efficacy of Anticoagulant Therapy in Pediatric Catheter-related Venous Thrombosis (EINSTEIN-Jr. CVC-VTE): A Pre-specified Substudy

Researchers

Presenter

  • K. Thom

Principal Investigators

  • A.W.A. Lensing

  • D. Kubitza

  • A.F. Pap

  • M.H. Prins

  • G. Kenet

  • M.P. Massicotte

  • A.K. Chan

  • P. Monagle

  • G. Young

  • C. Male

Medical Centers

  • Medical University of Vienna, Department of Paediatrics, Division of Paediatric Cardiology, Vienna, Austria

  • Bayer Pharma AG, Berlin, Germany

  • Maastricht University Medical Centre, Department of Epidemiology and Medical Technology Assessment, Maastricht, Netherlands

  • Sackler Faculty of Medicine, Tel Aviv University, Israeli National Hemophilia Center and Thrombosis Unit, Tel Hashomer, Israel

  • University of Alberta, Department of Paediatrics, Edmonton, Canada

  • McMaster University, McMaster Children's Hospital, Hamilton, Canada

  • Royal Childrens Hospital, Department of Respiratory Medicine, Melbourne, Australia

  • University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, Los Angeles, CA

Locations

  • Austria

  • Germany

  • Netherlands

  • Israel

  • Canada

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved